Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden

Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden

Background and Purpose Neurofilament light chain (NfL) is a blood marker for neuroaxonal damage. We assessed the association between serum NfL and cerebral small vessel disease (SVD), which is highly prevalent in elderly individuals and a major cause of stroke and vascular cognitive impairment. Meth...

Full description

Bibliographic Details
Main Authors:	Marco Duering, Marek J. Konieczny, Steffen Tiedt, Ebru Baykara, Anil Man Tuladhar, Esther van Leijsen, Philippe Lyrer, Stefan T. Engelter, Benno Gesierich, Melanie Achmüller, Christian Barro, Ruth Adam, Michael Ewers, Martin Dichgans, Jens Kuhle, Frank-Erik de Leeuw, Nils Peters
Format:	Article
Language:	English
Published:	Korean Stroke Society 2018-05-01
Series:	Journal of Stroke
Subjects:	biomarkers serum cerebral small vessel diseases magnetic resonance imaging dementia, vascular
Online Access:	http://www.j-stroke.org/upload/pdf/jos-2017-02565.pdf

Similar Items

Serum Neurofilament Light Chain Is Associated with Incident Lacunes in Progressive Cerebral Small Vessel Disease
by: Nils Peters, et al.
Published: (2020-09-01)

Increased Neurofilament Light Chain Is Associated with Increased Risk of Long-Term Mortality in Cerebral Small Vessel Disease
by: Mina A. Jacob, et al.
Published: (2022-05-01)

Cognition mediates the relation between structural network efficiency and gait in small vessel disease
by: Mengfei Cai, et al.
Published: (2021-01-01)

Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
by: Antoinette Depoorter, et al.
Published: (2018-11-01)

Network structure-function coupling and neurocognition in cerebral small vessel disease
by: Jonathan Tay, et al.
Published: (2023-01-01)

Determining the OPTIMAL DTI analysis method for application in cerebral small vessel disease
by: Marco Egle, et al.
Published: (2022-01-01)

Renal Function and Body Mass Index Contribute to Serum Neurofilament Light Chain Levels in Elderly Patients With Atrial Fibrillation
by: Alexandros A. Polymeris, et al.
Published: (2022-04-01)

Cervical and intracranial artery dissections
by: Stefan T. Engelter, et al.
Published: (2021-08-01)

Automated Morphological Analysis of Microglia After Stroke
by: Steffanie Heindl, et al.
Published: (2018-04-01)

Longitudinal changes in rich club organization and cognition in cerebral small vessel disease
by: Esther M.C. van Leijsen, et al.
Published: (2019-01-01)

Longitudinal serum neurofilament light kinetics in post‐anoxic encephalopathy
by: Giulio Disanto, et al.
Published: (2023-12-01)

Real-time video analysis allows the identification of large vessel occlusion in patients with suspected stroke: feasibility trial of a “telestroke” pathway in Northwestern Switzerland
by: Sebastian Thilemann, et al.
Published: (2023-10-01)

Decreased neurofilament light chain levels in estriol‐treated multiple sclerosis
by: Rhonda Voskuhl, et al.
Published: (2022-08-01)

Multicenter evaluation of neurofilaments in early symptomatic amyotrophic lateral sclerosis
by: Feneberg, E, et al.
Published: (2017)

Pro-inflammatory Monocyte Phenotype During Acute Progression of Cerebral Small Vessel Disease
by: Marlies P. Noz, et al.
Published: (2021-05-01)

Carotid artery stenting
by: Leo H. Bonati, et al.
Published: (2012-07-01)

Neurofilament Light Chain Concentration in Cerebrospinal Fluid in Children with Acute Nontraumatic Neurological Disorders
by: Tobias Geis, et al.
Published: (2024-03-01)

Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis.
by: Kuhle, J, et al.
Published: (2011)

Case Report: A 72-Year-Old Woman With Progressive Motor Weakness, Dry Eyes and High Levels of Serum Neurofilament Light Chain
by: Maria Janina Wendebourg, et al.
Published: (2022-07-01)

ADC histograms from routine DWI for longitudinal studies in cerebral small vessel disease: a field study in CADASIL.
by: Bence Gunda, et al.
Published: (2014-01-01)

Serum Neurofilament Light Chain: A Marker of Nervous System Damage in Myopathies
by: Annika Saak, et al.
Published: (2021-12-01)

Serum neurofilament light chain in COVID-19 and the influence of renal function
by: Peter Körtvelyessy, et al.
Published: (2023-09-01)

Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study
by: Dejan Jakimovski, et al.
Published: (2019-09-01)

Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters
by: Marco Hermesdorf, et al.
Published: (2022-09-01)

Temporal Patterning of Neurofilament Light as a Blood-Based Biomarker for Stroke: A Systematic Review and Meta-Analysis
by: Jasmin D. Sanchez, et al.
Published: (2022-05-01)

Confounding effect of blood volume and body mass index on blood neurofilament light chain levels
by: Ali Manouchehrinia, et al.
Published: (2020-01-01)

Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective study
by: Sabina Hunziker, et al.
Published: (2021-01-01)

Impact of ongoing intravenous thrombolysis until completion of endovascular treatment in large vessel occlusion stroke patients
by: Johannes Wischmann, et al.
Published: (2023-08-01)

Neurofilament Light Chain serum levels after Hypoxia-Ischemia in a newborn piglet model
by: Kasper Jacobsen Kyng, et al.
Published: (2023-01-01)

Predictive value of serum neurofilament light chain for persistent cognitive deficits in elderly depressive patients
by: Christoph Linnemann, et al.
Published: (2021-04-01)

Ratio and index of Neurofilament light chain indicate its origin in Guillain‐Barré Syndrome
by: Peter Körtvelyessy, et al.
Published: (2020-11-01)

Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis
by: Ngoc Dung Le, et al.
Published: (2020-10-01)

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.
by: Johanna Gaiottino, et al.
Published: (2013-01-01)

Evidence of polygenic regulation of the physiological presence of neurofilament light chain in human serum
by: Marisol Herrera-Rivero, et al.
Published: (2023-03-01)

Neurofilaments and traumatic brain injury
by: Mariusz Kobek, et al.
Published: (2015-03-01)

Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management
by: Mark S. Freedman, et al.
Published: (2024-03-01)

White matter integrity in small vessel disease is related to cognition
by: Anil M. Tuladhar, et al.
Published: (2015-01-01)

Orthostatic hypotension is not associated with small vessel disease progression or cognitive decline
by: Mina A. Jacob, et al.
Published: (2021-01-01)

Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a analysis
by: Jens Kuhle, et al.
Published: (2024-03-01)

Gray Matter Covariance Networks as Classifiers and Predictors of Cognitive Function in Alzheimer’s Disease
by: Fabian Wagner, et al.
Published: (2020-05-01)